معرفی
James Ankrum, PhD, is a Professor in the Department of Biomedical Engineering at the University of Iowa, where he directs the Ankrum Lab. He holds key affiliations with the Fraternal Order of Eagles Diabetes Research Center, Pappajohn Biomedical Institute, and Iowa Technology Institute. His research focuses on cell-based therapies, immunomodulation, and metabolic disorders, particularly involving adipose tissue, pancreatic beta cells, and environmental toxicants.
His educational background includes a PhD in Medical Engineering and Medical Physics from Harvard-MIT Division of Health Sciences & Technology, an MPhil in Engineering Design from the University of Cambridge, and a BSE in Biomedical Engineering from the University of Iowa.
Research interests span:
- Cell-based therapies: Engineering immunomodulatory stem cells for regenerative applications.
- Microenvironmental control: How cellular niches influence phenotype in adipose and pancreatic systems.
- Toxicology: Impacts of pollutants like PCBs on metabolism, immunity, and endocrine function.
Recent publications (2024-2025) primarily investigate macrophage-stromal cell interactions in lipid-rich environments, PCB toxicity mechanisms, adipose tissue engineering, and beta cell dysfunction. Common themes include immunometabolic reprogramming, 3D tissue models, and environmental influences on cellular health.
Professional memberships include the American Society of Gene and Cell Therapy, Society for Biomaterials, and Biomedical Engineering Society. No awards or student advisees are listed in the provided text.
